Zymeworks (ZYME) Other Operating Expenses (2022 - 2026)
Zymeworks (ZYME) reported Other Operating Expenses of $765000.0 for Q1 2026, down 77.97% on a YoY basis from $3.5 million in Q1 2025, and down 71.38% sequentially from $2.7 million in Q4 2025.
Zymeworks (ZYME) Other Operating Expenses (2022 - 2026) Analysis & Trends
Zymeworks (ZYME) has 5 years of Other Operating Expenses data on file, last reported at $765000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Operating Expenses fell 77.97% year-over-year to $765000.0; the trailing twelve-month figure through Mar 2026 stood at $10.1 million (down 43.17% YoY), and the FY2025 full-year result was $12.8 million, down 37.58% from the prior year.
- Other Operating Expenses declined to $765000.0 in Q1 2026, from $2.7 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $6.2 million in Q1 2024 to a low of -$13000.0 in Q1 2022.
- A 5-year average of $3.4 million and a median of $3.8 million in 2025 frame the typical range for Other Operating Expenses.
- Across the five-year window, Other Operating Expenses surged 33315.38% in 2023 and sank 77.97% in 2026, its largest moves.
- Tracing ZYME's Other Operating Expenses over 5 years: stood at $1.0 million in 2022, then jumped by 305.09% to $4.2 million in 2023, then gained by 4.96% to $4.4 million in 2024, then tumbled by 39.61% to $2.7 million in 2025, then tumbled by 71.38% to $765000.0 in 2026.
- Business Quant data shows ZYME's Other Operating Expenses at $765000.0 in Q1 2026, $2.7 million in Q4 2025, and $3.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 765,000.00 |
| Dec 31, 2025 | 2.67 Mn |
| Sep 30, 2025 | 3.84 Mn |
| Jun 30, 2025 | 2.81 Mn |
| Mar 31, 2025 | 3.47 Mn |
| Dec 31, 2024 | 4.43 Mn |
| Sep 30, 2024 | 4.58 Mn |
| Jun 30, 2024 | 5.27 Mn |
| Mar 31, 2024 | 6.22 Mn |
| Dec 31, 2023 | 4.22 Mn |
| Sep 30, 2023 | 5.66 Mn |
| Jun 30, 2023 | 4.62 Mn |
| Mar 31, 2023 | 4.32 Mn |
| Dec 31, 2022 | 1.04 Mn |
| Sep 30, 2022 | 2.48 Mn |
| Jun 30, 2022 | 1.20 Mn |
| Mar 31, 2022 | -13,000.00 |